Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiation
Philipp Nold(Universitätsklinikum Gießen und Marburg), Cornelia Brendel(Philipps University of Marburg), Madeleine C. Killer, Anne Neumann(BOKU University), Andreas Neubauer(RWTH Aachen University), Christina Barckhausen(Philipps University of Marburg), Holger Hackstein(Justus-Liebig-Universität Gießen), Cornelia Kasper(BOKU University), Tabea Riedlinger, Marco Mernberger(Philipps University of Marburg), Jan Schmitt(Technical University of Applied Sciences Würzburg-Schweinfurt), Susanne Fuchs‐Winkelmann(Philipps University of Marburg), Christian Fölsch(Philipps University of Marburg)
Cited by 37
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)
|Journal of Clinical Oncology|2005|573